Viewing data from:

RAMELTEON

ANDA

RAMELTEON | A211567 | ZYDUS PHARMACEUTICALS USA INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: ROZEREM(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.6898

per ea

Lowest NADAC/Unit

$0.6898

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
70710134401RAMELTEON 8 MG TABLET	$0.6898	EA	Generic	—	2026-06-17
70710134403RAMELTEON 8 MG TABLET	$0.6898	EA	Generic	—	2026-06-17
60687069265RAMELTEON 8 MG TABLET	$0.6898	EA	Generic	—	2026-06-17
00904749406RAMELTEON 8 MG TABLET	$0.6898	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs

7 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVRAMELTEON

DMF 228822009

MSN LABORATORIES PRIVATE LTDRAMELTEON

DMF 315062017

SS PHARMA LLCRAMELTEON

DMF 324442018

ENALTEC LABS PRIVATE LTDRAMELTEON

DMF 336012019

ZHEJIANG AUSUN PHARMACEUTICAL CO LTDRAMELTEON

DMF 337192019

BIOPHORE INDIA PHARMACEUTICALS PVT LTDRAMELTEON

DMF 344142019

APITORIA PHARMA PRIVATE LTDRAMELTEON

DMF 348992020

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 8MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jul 22, 2019

No patent or exclusivity listings for this strength.